Deloitte has purchased substantially all of the assets of CasePointer, the disease surveillance business of End Point, in an effort to help drive the growth of its public health transformation team. The company said Monday the acquisition bolsters Deloitte’s government service offerings with the addition of experienced public health professionals and engineers and open-source disease